NCT03948724View on ClinicalTrials.gov

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

NACompletedINTERVENTIONAL
Enrollment

411

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

August 4, 2023

Study Completion Date

August 22, 2024

Conditions
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanomaAdvanced Non-small Cell Lung CancerRenal Cell CarcinomaHead and Neck CancerImmune-related Adverse Event
Interventions
BEHAVIORAL

Therapeutic education program

Patient will have 5 educational therapy workshops. The first educational therapy workshops will be realized at cycle 1 and the last one within 25 weeks after starting treatment

BEHAVIORAL

Usual Information

Patient receive usual informations

Trial Locations (9)

14000

Centre Francois Baclesse, Caen

37170

Centre D'Oncologie Et de Radiotherapie 37, Chambray-lès-Tours

49055

Chu Angers, Angers

Institut de Cancerologie de L'Ouest, Angers

54519

Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy

59020

Centre Oscar Lambret, Lille

63373

Centre Leon Berard, Lyon

75005

Institut Curie, Paris

85925

Chd Vendee, La Roche-sur-Yon

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER

NCT03948724 - Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology | Biotech Hunter | Biotech Hunter